Systems Oncology Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Series B

  • Investors
  • 2

Systems Oncology General Information

Description

Developer of cancer treatment drugs designed to accelerate scientific innovations into breakthrough cancer therapies. The company's drugs are created by utilizing advanced cognitive computing technologies to mine big data for hidden biomedical insights, integrating big-data aggregation and mechanistic analysis, enabling researchers to identify novel therapeutic opportunities, accelerate drug discovery, and improve patient outcomes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 7201 East Henkel Way
  • Suite 205
  • Scottsdale, AZ 85255
  • United States
+1 (480)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 7201 East Henkel Way
  • Suite 205
  • Scottsdale, AZ 85255
  • United States
+1 (480)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Systems Oncology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series B) 22-Oct-2019 Completed Generating Revenue
1. Early Stage VC Completed Startup
To view Systems Oncology’s complete valuation and funding history, request access »

Systems Oncology Patents

Systems Oncology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3217459-A1 Compositions for inhibiting growth of targeted cells Pending 06-May-2021
US-20240229033-A1 Compositions for inhibiting growth of targeted cells Pending 06-May-2021
WO-2022235971-A2 Compositions for inhibiting growth of targeted cells Inactive 06-May-2021
WO-2022235971-A3 Compositions for inhibiting growth of targeted cells Inactive 06-May-2021
WO-2022235971-A9 Compositions for inhibiting growth of targeted cells Inactive 06-May-2021 C12N15/113
To view Systems Oncology’s complete patent history, request access »

Systems Oncology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Systems Oncology Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
The Pritzker Organization Merchant Banking Firm Minority
Lakeshore Capital Partners Growth/Expansion Minority
To view Systems Oncology’s complete investors history, request access »

Systems Oncology FAQs

  • When was Systems Oncology founded?

    Systems Oncology was founded in 2015.

  • Where is Systems Oncology headquartered?

    Systems Oncology is headquartered in Scottsdale, AZ.

  • What is the size of Systems Oncology?

    Systems Oncology has 12 total employees.

  • What industry is Systems Oncology in?

    Systems Oncology’s primary industry is Drug Discovery.

  • Is Systems Oncology a private or public company?

    Systems Oncology is a Private company.

  • What is Systems Oncology’s current revenue?

    The current revenue for Systems Oncology is .

  • Who are Systems Oncology’s investors?

    The Pritzker Organization and Lakeshore Capital Partners have invested in Systems Oncology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process